Title : Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions.

Pub. Date : 2013 Aug 20

PMID : 23867999






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. Carboplatin BRCA1 DNA repair associated Homo sapiens
2 BACKGROUND: We tested the hypothesis that BRCA1/2 mutation carriers with ovarian cancer are at higher risk of carboplatin hypersensitivity reactions (HSRs). Carboplatin BRCA1 DNA repair associated Homo sapiens
3 Most patients who developed carboplatin HSR had a deleterious BRCA1/2 mutation (93%) vs 50% in patients without HSR (P<0.0001). Carboplatin BRCA1 DNA repair associated Homo sapiens
4 Multivariable analysis accounting for potential confounding variables including age, history of allergies, and cumulative prior carboplatin cycles confirmed deleterious BRCA1/2 mutation as an independent risk factor for carboplatin HSR (odds ratio 13.1 (95% confidence interval 2.6-65.4), P=0.0017). Carboplatin BRCA1 DNA repair associated Homo sapiens
5 CONCLUSION: Deleterious BRCA1/2 mutation increased susceptibility and shortened time to carboplatin HSR, independently of other reported factors. Carboplatin BRCA1 DNA repair associated Homo sapiens